Positive results have been presented on Datroway (datopotamab deruxtecan) from the TROPION-Breast02 Phase III trial at the ...
DESTINY-Breast05 Phase III trial data has shown that Enhertu (trastuzumab deruxtecan) led to a highly statistically ...
More positive data has been presented at the ESMO Congress on Enhertu (trastuzumab deruxtecan), a specifically engineered ...
Germany’s Merck KGaA has presented longer-term results from the global Phase III MANEUVER trial evaluating pimicotinib at the ...
Roche late Friday released results from two Phase III studies - dubbed MEERKAT and SANDCAT - evaluating the efficacy and ...
Isotope Technologies Munich (ITM) has announced a higher objective response rate (ORR) and prolonged median progression-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback